Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions.
The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like Ambu® aScope™ – the world’s first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on your work.
Headquartered near Copenhagen in Denmark, Ambu employs approximately 4,000+ people in Europe, North America and the Asia Pacific.
1937
Headcount4,500
HeadquartersBaltorpbakken 13, 2750 Ballerup – Denmark
Line item in (dkk) | 01.10.2020 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 |
---|---|---|---|---|---|---|---|
Assets | N/A | 5,740,000,000.00 | 6,327,000,000.00 | 6,557,000,000.00 | 7,215,000,000.00 | 7,006,000,000.00 | 6,937,000,000.00 |
Noncurrent Assets | N/A | 4,132,000,000.00 | 4,517,000,000.00 | 4,642,000,000.00 | 4,911,000,000.00 | 4,791,000,000.00 | 4,817,000,000.00 |
Property Plant And Equipment | N/A | 846,000,000.00 | 594,000,000.00 | 606,000,000.00 | 686,000,000.00 | 657,000,000.00 | 650,000,000.00 |
Land And Buildings | N/A | 403,000,000.00 | N/A | N/A | 732,000,000.00 | N/A | N/A |
Machinery | N/A | 164,000,000.00 | N/A | N/A | 178,000,000.00 | N/A | N/A |
Fixtures And Fittings | N/A | 169,000,000.00 | N/A | N/A | 185,000,000.00 | N/A | N/A |
Construction In Progress | N/A | 110,000,000.00 | N/A | N/A | 181,000,000.00 | N/A | N/A |
Goodwill | N/A | 1,504,000,000.00 | 1,518,000,000.00 | 1,531,000,000.00 | 1,623,000,000.00 | 1,558,000,000.00 | 1,545,000,000.00 |
Copyrights Patents And Other Industrial Property Rights Service And Operating Rights | N/A | 42,000,000.00 | 40,000,000.00 | 37,000,000.00 | 27,000,000.00 | 25,000,000.00 | 29,000,000.00 |
Intangible Assets Under Development | N/A | 572,000,000.00 | 648,000,000.00 | 457,000,000.00 | 458,000,000.00 | 457,000,000.00 | 506,000,000.00 |
Deferred Tax Assets | N/A | 42,000,000.00 | 51,000,000.00 | 74,000,000.00 | 70,000,000.00 | 70,000,000.00 | 85,000,000.00 |
Other Noncurrent Assets | N/A | 42,000,000.00 | N/A | N/A | 70,000,000.00 | N/A | N/A |
Current Assets | N/A | 1,608,000,000.00 | 1,810,000,000.00 | 1,915,000,000.00 | 2,304,000,000.00 | 2,215,000,000.00 | 2,120,000,000.00 |
Inventories | N/A | 748,000,000.00 | 905,000,000.00 | 991,000,000.00 | 1,222,000,000.00 | 1,209,000,000.00 | 1,086,000,000.00 |
Current Tax Assets Current | N/A | 13,000,000.00 | 9,000,000.00 | 9,000,000.00 | 23,000,000.00 | 31,000,000.00 | 45,000,000.00 |
Cash and cash equivalents | 98,000,000.00 | 64,000,000.00 | 141,000,000.00 | 112,000,000.00 | 187,000,000.00 | 125,000,000.00 | 182,000,000.00 |
Current Derivative Financial Assets | N/A | 0.00 | 0.00 | 0.00 | 11,000,000.00 | 12,000,000.00 | 12,000,000.00 |
Equity And Liabilities | N/A | 5,740,000,000.00 | 6,327,000,000.00 | 6,557,000,000.00 | 7,215,000,000.00 | 7,006,000,000.00 | 6,937,000,000.00 |
Equity | 2,372,000,000.00 | 3,952,000,000.00 | 3,946,000,000.00 | 4,162,000,000.00 | 4,261,000,000.00 | 4,122,000,000.00 | 5,212,000,000.00 |
Issued Capital | N/A | 129,000,000.00 | 129,000,000.00 | 129,000,000.00 | 129,000,000.00 | 129,000,000.00 | 135,000,000.00 |
Other Reserves | N/A | 3,823,000,000.00 | 3,817,000,000.00 | 4,033,000,000.00 | 4,132,000,000.00 | 3,993,000,000.00 | 5,077,000,000.00 |
Liabilities | N/A | 1,788,000,000.00 | 2,381,000,000.00 | 2,395,000,000.00 | 2,954,000,000.00 | 2,884,000,000.00 | 1,725,000,000.00 |
Noncurrent Liabilities | N/A | 808,000,000.00 | 1,368,000,000.00 | 1,531,000,000.00 | 1,793,000,000.00 | 1,888,000,000.00 | 859,000,000.00 |
Other Longterm Provisions | N/A | 30,000,000.00 | 29,000,000.00 | 31,000,000.00 | 19,000,000.00 | 18,000,000.00 | 18,000,000.00 |
Deferred Tax Liabilities | N/A | 18,000,000.00 | 23,000,000.00 | 39,000,000.00 | 8,000,000.00 | 10,000,000.00 | 8,000,000.00 |
Other Noncurrent Financial Liabilities | N/A | 760,000,000.00 | N/A | N/A | 1,766,000,000.00 | N/A | N/A |
Longterm Borrowings | N/A | N/A | 860,000,000.00 | 985,000,000.00 | 1,250,000,000.00 | 1,380,000,000.00 | 340,000,000.00 |
Current Liabilities | N/A | 980,000,000.00 | 1,013,000,000.00 | 864,000,000.00 | 1,161,000,000.00 | 996,000,000.00 | 866,000,000.00 |
Other Shortterm Provisions | N/A | 13,000,000.00 | 15,000,000.00 | 14,000,000.00 | 4,000,000.00 | 4,000,000.00 | 4,000,000.00 |
Current Tax Liabilities Current | N/A | 23,000,000.00 | 23,000,000.00 | 26,000,000.00 | 17,000,000.00 | 7,000,000.00 | 7,000,000.00 |
Other Current Financial Liabilities | N/A | 63,000,000.00 | N/A | N/A | 79,000,000.00 | N/A | N/A |
Other Current Nonfinancial Liabilities | N/A | 137,000,000.00 | 141,000,000.00 | N/A | 0.00 | 0.00 | N/A |
Current Derivative Financial Liabilities | N/A | 2,000,000.00 | 1,000,000.00 | N/A | 0.00 | 0.00 | N/A |
Line item in (dkk) | 01.10.2020/ 01.10.2021 |
01.10.2021/ 01.01.2022 |
01.10.2021/ 01.04.2022 |
01.10.2021/ 01.10.2022 |
01.01.2022/ 01.04.2022 |
01.10.2022/ 01.01.2023 |
01.10.2022/ 01.04.2023 |
01.01.2023/ 01.04.2023 |
---|---|---|---|---|---|---|---|---|
Revenue | 4,013,000,000.00 | 1,031,000,000.00 | 2,153,000,000.00 | 4,444,000,000.00 | 1,122,000,000.00 | 1,132,000,000.00 | 2,321,000,000.00 | 1,189,000,000.00 |
Profit Loss From Operating Activities | 340,000,000.00 | 40,000,000.00 | 87,000,000.00 | -26,000,000.00 | 47,000,000.00 | 68,000,000.00 | 114,000,000.00 | 46,000,000.00 |
Finance Income | 8,000,000.00 | 0.00 | 137,000,000.00 | 169,000,000.00 | 137,000,000.00 | 1,000,000.00 | 0.00 | -1,000,000.00 |
Finance Costs | 40,000,000.00 | 15,000,000.00 | 17,000,000.00 | 34,000,000.00 | 2,000,000.00 | 41,000,000.00 | 67,000,000.00 | 26,000,000.00 |
Profit Loss Before Tax | 308,000,000.00 | 25,000,000.00 | 207,000,000.00 | 109,000,000.00 | 182,000,000.00 | 28,000,000.00 | 47,000,000.00 | 19,000,000.00 |
Income Tax Expense Continuing Operations | 61,000,000.00 | 5,000,000.00 | 12,000,000.00 | 16,000,000.00 | 7,000,000.00 | 6,000,000.00 | 10,000,000.00 | 4,000,000.00 |
Profit (loss) | 247,000,000.00 | 20,000,000.00 | 195,000,000.00 | 93,000,000.00 | 175,000,000.00 | 22,000,000.00 | 37,000,000.00 | 15,000,000.00 |
Line item in (dkk) | 01.10.2020 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 |
---|---|---|---|---|---|---|---|
Profit (loss) | N/A | 247,000,000.00 | 20,000,000.00 | 175,000,000.00 | 93,000,000.00 | 22,000,000.00 | 15,000,000.00 |
Adjustments For Reconcile Profit Loss | N/A | 227,000,000.00 | N/A | N/A | 363,000,000.00 | N/A | N/A |
Adjustments For Income Tax Expense | N/A | N/A | 5,000,000.00 | 12,000,000.00 | 16,000,000.00 | 6,000,000.00 | 10,000,000.00 |
Adjustments For Depreciation And Amortisation Expense | N/A | N/A | 62,000,000.00 | 140,000,000.00 | 351,000,000.00 | 77,000,000.00 | 154,000,000.00 |
Adjustments For Reconcile Profit Loss | N/A | 227,000,000.00 | N/A | N/A | 363,000,000.00 | N/A | N/A |
Interest Paid Classified As Operating Activities | N/A | 18,000,000.00 | 3,000,000.00 | 13,000,000.00 | 29,000,000.00 | 13,000,000.00 | 40,000,000.00 |
Interest Received Classified As Operating Activities | N/A | 3,000,000.00 | N/A | N/A | 0.00 | N/A | N/A |
Cash Flows From Used In Operating Activities | N/A | 328,000,000.00 | -28,000,000.00 | -23,000,000.00 | 95,000,000.00 | -98,000,000.00 | 1,000,000.00 |
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 298,000,000.00 | 0.00 | 0.00 | 5,000,000.00 | 0.00 | 0.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 176,000,000.00 | 35,000,000.00 | 71,000,000.00 | 158,000,000.00 | 26,000,000.00 | 45,000,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 405,000,000.00 | 99,000,000.00 | 204,000,000.00 | 395,000,000.00 | 50,000,000.00 | 109,000,000.00 |
Proceeds From Other Longterm Assets Classified As Investing Activities | N/A | 8,000,000.00 | N/A | N/A | 0.00 | N/A | N/A |
Cash Flows From Used In Investing Activities | N/A | -874,000,000.00 | -134,000,000.00 | -275,000,000.00 | -558,000,000.00 | -76,000,000.00 | -154,000,000.00 |
Proceeds From Issuing Shares | N/A | 1,225,000,000.00 | 0.00 | 1,000,000.00 | 1,000,000.00 | 0.00 | 1,054,000,000.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | N/A | 310,000,000.00 | 435,000,000.00 | 825,000,000.00 | 130,000,000.00 | 230,000,000.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 1,250,000,000.00 | 0.00 | 0.00 | 125,000,000.00 | 0.00 | 1,140,000,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 44,000,000.00 | 12,000,000.00 | 27,000,000.00 | 52,000,000.00 | 18,000,000.00 | 33,000,000.00 |
Dividends Paid Classified As Financing Activities | N/A | 73,000,000.00 | 60,000,000.00 | 75,000,000.00 | 75,000,000.00 | 0.00 | 0.00 |
Cash Flows From Used In Financing Activities | N/A | 512,000,000.00 | 239,000,000.00 | 346,000,000.00 | 586,000,000.00 | 112,000,000.00 | 148,000,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -34,000,000.00 | 77,000,000.00 | 48,000,000.00 | 123,000,000.00 | -62,000,000.00 | -5,000,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 0.00 | N/A | N/A | 0.00 | N/A | N/A |
Cash and cash equivalents | 98,000,000.00 | 64,000,000.00 | 141,000,000.00 | 112,000,000.00 | 187,000,000.00 | 125,000,000.00 | 182,000,000.00 |
Please note that some sums might not add up.
DK0060946788
LEI5299008W2A69WX355710
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryOMX Copenhagen 20
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.